AUSTRALIA, 3 SEPTEMBER 2020 - LeafCann is excited to announce an exclusive agreement with The Green Organic Dutchman (“TGOD”), a leading producer of premium certified organically grown cannabis headquartered in Canada. The agreement will see LeafCann as TGOD’s exclusive supplier of the TGOD range of Medicinal Cannabis products in Australia and New Zealand.
TGOD CEO, Brian Athaide, welcomed this highly anticipated agreement. “Australia and New Zealand are gradually discovering the therapeutic benefits of cannabis. With our roots in the medical segment, TGOD produces high-quality, consistent products using premium certified organically grown cannabis that meet the highest standards, as evidenced by the obtention of our EU-GMP certification. LeafCann’s patient-centred approach makes them an ideal partner to bring our vision of Making Life Better to the Australian and New Zealand markets.”
LeafCann CEO, Elisabetta Faenza, was delighted to sign the agreement with TGOD, particularly in the current environment of consolidation within the medicinal cannabis sector. “TGOD has established itself as a respected market leader and trusted producer of high-quality EU GMP organic product. I’m excited to work with TGOD on this venture and can’t wait until it is prescribed for Australian patients who value the contaminant free assurance that organic products provide.”
LeafCann Chairman, Ilario Faenza, agrees. “We really respect the management team at TGOD and know the quality of their product reflects TGOD’s dedication to being the best organic cannabis producer in the world. This is a beneficial arrangement for both sides, and I look forward to a long and productive relationship.”
The TGOD product range provides health practitioners with a safe alternative for patients who rely on quality products that are certified organically grown. The range is also reliable in its consistency and maintains its cannabinoid content, down to the last drop in the bottle, something patients have found frustrating in other products where potency can degrade over time once a bottle has been opened.
“The peace of mind a reliable product provides to patients cannot be underestimated” said LeafCann Chief Scientist, Dr Jaroslav Boublik. “Patients have the right to demand the best medicine they can get to treat their condition and they will get that with the TGOD range of products. We searched the world for the best organic product that maintains its consistency and is good value for money. This is a great win for the Australian and New Zealand markets.”
The TGOD product range is expected to be available to Australian patients within the next six months and will be available by prescription only through a qualified healthcare professional. Media enquiries can be directed to LeafCann CEO, Elisabetta Faenza.
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US‐OTC: TGODF) is a premium certified organically grown cannabis company focused on the health and wellness market. Its organic cannabis is cultivated in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities have been built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD sells dried flower and oil, and recently launched a series of next‐generation cannabis products such as organic teas, dissolvables and vapes. Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil and CBD-infused topicals in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale.
TGOD's Common Shares and warrants issued under the indentures dated November 1, 2017 and December 19, 2019 trade on the TSX under the symbol "TGOD", "TGOD.WT", "TGOD.WS" and "TGOD.WR", respectively, and TGODF trades in the US on the OTCQX. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
About LeafCann Group Pty Ltd.
LeafCann is an Australian licenced, vertically integrated biotech company specialising in the production of high quality, pharmaceutical grade cannabis ingredients and medicines.
Leafcann has become Australia’s thought leading pioneer in the medicinal cannabis sector. As Australia’s leading privately owned medicinal cannabis company, Leafcann’s philosophy is Patient first. Our world-class management team and leading international professionals on our advisory board bring decades of combined experience working with and in regulated Medical Cannabis Schemes. LeafCann’s promise is to provide the highest quality, consistent product, at affordable prices, creating great value for patients and reliable dosing for physicians.
For further information:
Elisabetta Faenza
CEO, LeafCann Group Pty Ltd
Email: ef@leafcann.com
Sebastien Bouchard
Corporate Communications
Email: sbouchard@tgod.ca
